Alliancebernstein L.P. Personalis, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.27 - $8.76 $109,872 - $294,336	-33,600 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.56 - $14.3 $756 - $1,430	100 Added 0.3%	33,600 $275,000
Q2 2021 Jul 30, 2021	BUY	$18.15 - $27.75 $259,544 - $396,825	14,300 Added 74.48%	33,500 $848,000
Q1 2021 May 06, 2021	SELL	$20.71 - $51.02 $159,467 - $392,854	-7,700 Reduced 28.62%	19,200 $473,000
Q4 2020 Feb 08, 2021	SELL	$21.84 - $44.0 $32,760 - $66,000	-1,500 Reduced 5.28%	26,900 $985,000
Q3 2020 Nov 12, 2020	SELL	$13.63 - $24.12 $106,314 - $188,136	-7,800 Reduced 21.55%	28,400 $615,000
Q2 2020 Aug 13, 2020	BUY	$7.65 - $14.11 $32,895 - $60,673	4,300 Added 13.48%	36,200 $470,000
Q1 2020 May 14, 2020	BUY	$4.75 - $12.41 $151,525 - $395,879	31,900 New	31,900 $257,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $159M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.